Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies

被引：0
|
作者：
Elena Grebenciucova
Amy Pruitt
机构：
[1] Northwestern University Feinberg School of Medicine,Multiple Sclerosis Division, Davee Department of Neurology and Clinical Neurosciences
[2] The University of Pennsylvania,Multiple Sclerosis Division, the Department of Neurology, Perelman School of Medicine
来源：
Current Neurology and Neuroscience Reports | 2017年 / 17卷
关键词：
Multiple sclerosis disease-modifying therapy; Central nervous system opportunistic infections; Progressive multifocal leukoencephalopathy; Fingolimod; Natalizumab; Ocrelizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [2] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [3] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [4] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [5] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    [J]. NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [6] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [7] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    [J]. Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
  • [8] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Simona Lattanzi
    Maura Danni
    Ruja Taffi
    Raffaella Cerqua
    Giulia Carlini
    Alessandra Pulcini
    Leandro Provinciali
    Mauro Silvestrini
    [J]. Journal of Neurology, 2017, 264 : 2325 - 2329
  • [9] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Lattanzi, Simona
    Danni, Maura
    Taffi, Ruja
    Cerqua, Raffaella
    Carlini, Giulia
    Pulcini, Alessandra
    Provinciali, Leandro
    Silvestrini, Mauro
    [J]. JOURNAL OF NEUROLOGY, 2017, 264 (11) : 2325 - 2329
  • [10] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    [J]. Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
12345